Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Michel Tremblay
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Anatomy
Physiology
Disorders
Chemicals & Drugs
Sign-in to see full Profile
Network (preview)
19
Barbeau, Benoit
15
Barat, Corinne
13
Cantin, Réjean
12
Fortin, Jean-Francois
11
Tardif, Mélanie
10
Ouellet, Michel
9
Bergeron, Michel
8
Désormeaux, André
8
Bounou, Salim
8
Gilbert, Caroline
6
Dumais, Nancy
6
Vidricaire, Gaël
5
Zhao, Chenqi
5
Robichaud, Gilles
5
Olivier, Martin
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Michel Tremblay (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Diou Juliette; Gauthier Sonia; Tardif Mélanie R; Fromentin Rémi; Lodge Robert; Sullivan David J; Tremblay Michel J
Ingestion of the malaria pigment hemozoin renders human macrophages less permissive to HIV-1 infection.
Virology 2009;395(1):56-66.
-
2009: Tardif Mélanie R; Gilbert Caroline; Thibault Sandra; Fortin Jean-François; Tremblay Michel J
LFA-1 antagonists as agents limiting human immunodeficiency virus type 1 infection and transmission and potentiating the effect of the fusion inhibitor T-20.
Antimicrobial agents and chemotherapy 2009;53(11):4656-66.
-
2009: Imbeault Michaël; Lodge Robert; Ouellet Michel; Tremblay Michel J
Efficient magnetic bead-based separation of HIV-1-infected cells using an improved reporter virus system reveals that p53 up-regulation occurs exclusively in the virus-expressing cell population.
Virology 2009;393(1):160-7.
-
2009: Thibault Sandra; Imbeault Michaël; Tardif Mélanie R; Tremblay Michel J
TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+ T cells.
Virology 2009;389(1-2):20-5.
-
2009: Maurais Emilie; Cantin Réjean; Tremblay Michel J
Human immunodeficiency virus type 1-anchored CD40 ligand induces secretion of the chemokine interleukin-8 by human primary macrophages.
Virology 2009;385(1):227-32.
-
2009: Garg Ravendra; Barat Corinne; Ouellet Michel; Lodge Robert; Tremblay Michel J
Leishmania infantum Amastigotes Enhance HIV-1 Production in Cocultures of Human Dendritic Cells and CD4 T Cells by Inducing Secretion of IL-6 and TNF-alpha.
PLoS neglected tropical diseases 2009;3(5):e441.
-
2009: Thibault Sandra; Fromentin Rémi; Tardif Mélanie R; Tremblay Michel J
TLR2 and TLR4 triggering exerts contrasting effects with regard to HIV-1 infection of human dendritic cells and subsequent virus transfer to CD4+ T cells.
Retrovirology 2009;6():42.
-
2009: Ouellet Dominique L; Plante Isabelle; Barat Corinne; Tremblay Michel J; Provost Patrick
Emergence of a complex relationship between HIV-1 and the microRNA pathway.
Methods in molecular biology (Clifton, N.J.) 2009;487():415-33.
-
2009: Imbeault Michaël; Ouellet Michel; Tremblay Michel J
Microarray study reveals that HIV-1 induces rapid type-I interferon-dependent p53 mRNA up-regulation in human primary CD4+ T cells.
Retrovirology 2009;6():5.
-
2008: Garg Ravendra; Lodge Robert; Descoteaux Albert; Tremblay Michel J
Leishmania infantum promastigotes reduce entry of HIV-1 into macrophages through a lipophosphoglycan-mediated disruption of lipid rafts.
The Journal of infectious diseases 2008;197(12):1701-8.
-
2008: Simard Sébastien; Maurais Emilie; Gilbert Caroline; Tremblay Michel J
LPS reduces HIV-1 replication in primary human macrophages partly through an endogenous production of type I interferons.
Clinical immunology (Orlando, Fla.) 2008;127(2):198-205.
-
2008: Ouellet Dominique L; Plante Isabelle; Landry Patricia; Barat Corinne; Janelle Marie-Eve; Flamand Louis; Tremblay Michel J; Provost Patrick
Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element.
Nucleic acids research 2008;36(7):2353-65.
-
2008: El Fadili Karima; Imbeault Michaël; Messier Nadine; Roy Gaétan; Gourbal Benjamin; Bergeron Marc; Tremblay Michel J; Légaré Danielle; Ouellette Marc
Modulation of gene expression in human macrophages treated with the anti-leishmania pentavalent antimonial drug sodium stibogluconate.
Antimicrobial agents and chemotherapy 2008;52(2):526-33.
-
2008: Mercier Simon; St-Pierre Christian; Pelletier Isabelle; Ouellet Michel; Tremblay Michel J; Sato Sachiko
Galectin-1 promotes HIV-1 infectivity in macrophages through stabilization of viral adsorption.
Virology 2008;371(1):121-9.
-
2007: Thibault Sandra; Tardif Mélanie R; Barat Corinne; Tremblay Michel J
TLR2 signaling renders quiescent naive and memory CD4+ T cells more susceptible to productive infection with X4 and R5 HIV-type 1.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(7):4357-66.
-
2007: Thibault Sandra; Tardif Mélanie R; Gilbert Caroline; Tremblay Michel J
Virus-associated host CD62L increases attachment of human immunodeficiency virus type 1 to endothelial cells and enhances trans infection of CD4+ T lymphocytes.
The Journal of general virology 2007;88(Pt 9):2568-73.
-
2007: Barat Corinne; Martin Geneviève; Beaudoin Adrien R; Sévigny Jean; Tremblay Michel J
The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active.
Journal of molecular biology 2007;371(1):269-82.
-
2007: Garg Ravendra; Trudel Nathalie; Tremblay Michel J
Consequences of the natural propensity of Leishmania and HIV-1 to target dendritic cells.
Trends in parasitology 2007;23(7):317-24.
-
2007: Gilbert Caroline; Cantin Réjean; Barat Corinne; Tremblay Michel J
Human immunodeficiency virus type 1 replication in dendritic cell-T-cell cocultures is increased upon incorporation of host LFA-1 due to higher levels of virus production in immature dendritic cells.
Journal of virology 2007;81(14):7672-82.
-
2007: Flamand Louis; Tremblay Michel J; Borgeat Pierre
Leukotriene B4 triggers the in vitro and in vivo release of potent antimicrobial agents.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(12):8036-45.
-
2007: Martin Geneviève; Roy Jocelyn; Barat Corinne; Ouellet Michel; Gilbert Caroline; Tremblay Michel J
Human immunodeficiency virus type 1-associated CD40 ligand transactivates B lymphocytes and promotes infection of CD4+ T cells.
Journal of virology 2007;81(11):5872-81.
-
2007: Vidricaire Gael; Gauthier Sonia; Tremblay Michel J
HIV-1 infection of trophoblasts is independent of gp120/CD4 Interactions but relies on heparan sulfate proteoglycans.
The Journal of infectious diseases 2007;195(10):1461-71.
-
2007: Vidricaire Gaël; Tremblay Michel J
A clathrin, caveolae, and dynamin-independent endocytic pathway requiring free membrane cholesterol drives HIV-1 internalization and infection in polarized trophoblastic cells.
Journal of molecular biology 2007;368(5):1267-83.
-
2007: Gilbert Caroline; Barat Corinne; Cantin Réjean; Tremblay Michel J
Involvement of Src and Syk tyrosine kinases in HIV-1 transfer from dendritic cells to CD4+ T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(5):2862-71.
-
2007: Barat Corinne; Zhao Chenqi; Ouellette Marc; Tremblay Michel J
HIV-1 replication is stimulated by sodium stibogluconate, the therapeutic mainstay in the treatment of leishmaniasis.
The Journal of infectious diseases 2007;195(2):236-45.
-
2007: Breton Marie; Zhao Chenqi; Ouellette Marc; Tremblay Michel J; Papadopoulou Barbara
A recombinant non-pathogenic Leishmania vaccine expressing human immunodeficiency virus 1 (HIV-1) Gag elicits cell-mediated immunity in mice and decreases HIV-1 replication in human tonsillar tissue following exposure to HIV-1 infection.
The Journal of general virology 2007;88(Pt 1):217-25.
-
2006: Provost Patrick; Barat Corinne; Plante Isabelle; Tremblay Michel J
HIV-l and the microRNA-guided silencing pathway: an intricate and multifaceted encounter.
Virus research 2006;121(2):107-15.
-
2006: Zhao Chenqi; Thibault Sandra; Messier Nadine; Ouellette Marc; Papadopoulou Barbara; Tremblay Michel J
In primary human monocyte-derived macrophages exposed to Human immunodeficiency virus type 1, does the increased intracellular growth of Leishmania infantum rely on its enhanced uptake?
The Journal of general virology 2006;87(Pt 5):1295-302.
-
2005: Vidricaire Gaël; Tremblay Michel J
Rab5 and Rab7, but not ARF6, govern the early events of HIV-1 infection in polarized human placental cells.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(10):6517-30.
-
2005: Tardif Mélanie R; Tremblay Michel J
LFA-1 is a key determinant for preferential infection of memory CD4+ T cells by human immunodeficiency virus type 1.
Journal of virology 2005;79(21):13714-24.
-
2005: Breton Marie; Tremblay Michel J; Ouellette Marc; Papadopoulou Barbara
Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis.
Infection and immunity 2005;73(10):6372-82.
-
2005: Giguere Jean-Francois; Diou Juliette; Madrenas Joaquim; Tremblay Michel J
Virus attachment and replication are promoted after acquisition of host CD28 and CD152 by HIV-1.
The Journal of infectious diseases 2005;192(7):1265-8.
-
2005: Paré Marie-Eve; Gauthier Sonia; Landry Sébastien; Sun Jiangfeng; Legault Eric; Leclerc Denis; Tanaka Yuetsu; Marriott Susan J; Tremblay Michel J; Barbeau Benoit
A new sensitive and quantitative HTLV-I-mediated cell fusion assay in T cells.
Virology 2005;338(2):309-22.
-
2005: Tardif Mélanie R; Tremblay Michel J
Regulation of LFA-1 activity through cytoskeleton remodeling and signaling components modulates the efficiency of HIV type-1 entry in activated CD4+ T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(2):926-35.
-
2005: Cantin Réjean; Méthot Sylvie; Tremblay Michel J
Plunder and stowaways: incorporation of cellular proteins by enveloped viruses.
Journal of virology 2005;79(11):6577-87.
-
2005: Martin Geneviève; Beauséjour Yannick; Thibodeau Jacques; Tremblay Michel J
Envelope glycoproteins are dispensable for insertion of host HLA-DR molecules within nascent human immunodeficiency virus type 1 particles.
Virology 2005;335(2):286-90.
-
2005: Zhao Chenqi; Cantin Réjean; Breton Marie; Papadopoulou Barbara; Tremblay Michel J
DC-SIGN-mediated transfer of HIV-1 is compromised by the ability of Leishmania infantum to exploit DC-SIGN as a ligand.
The Journal of infectious diseases 2005;191(10):1665-9.
-
2005: Roy Jocelyn; Martin Geneviève; Giguère Jean-François; Bélanger Dave; Pétrin Myriam; Tremblay Michel J
HIV type 1 can act as an APC upon acquisition from the host cell of peptide-loaded HLA-DR and CD86 molecules.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(8):4779-88.
-
2005: Ouellet Michel; Mercier Simon; Pelletier Isabelle; Bounou Salim; Roy Jocelyn; Hirabayashi Jun; Sato Sachiko; Tremblay Michel J
Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(7):4120-6.
-
2005: Tardif Mélanie R; Tremblay Michel J
Tetraspanin CD81 provides a costimulatory signal resulting in increased human immunodeficiency virus type 1 gene expression in primary CD4+ T lymphocytes through NF-kappaB, NFAT, and AP-1 transduction pathways.
Journal of virology 2005;79(7):4316-28.
-
2005: Gilbert Caroline; Bergeron Marc; Méthot Sylvie; Giguère Jean-François; Tremblay Michel J
Statins could be used to control replication of some viruses, including HIV-1.
Viral immunology 2005;18(3):474-89.
-
2004: Lemieux Anne-Marie; Paré Marie-Eve; Audet Brigitte; Legault Eric; Lefort Sylvain; Boucher Nancy; Landry Sébastien; van Opijnen Tim; Berkhout Ben; Naghavi Mojgan H; Tremblay Michel J; Barbeau Benoit
T-cell activation leads to poor activation of the HIV-1 clade E long terminal repeat and weak association of nuclear factor-kappaB and NFAT with its enhancer region.
The Journal of biological chemistry 2004;279(51):52949-60.
-
2004: Langlois Mélanie; Audet Brigitte; Legault Eric; Paré Marie-Eve; Ouellet Michel; Roy Jocelyn; Dumais Nancy; Mesnard Jean-Michel; Rothstein David M; Marriott Susan J; Tremblay Michel J; Barbeau Benoit
Activation of HTLV-I gene transcription by protein tyrosine phosphatase inhibitors.
Virology 2004;329(2):395-411.
-
2004: Giguère Jean-François; Tremblay Michel J
Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1.
Journal of virology 2004;78(21):12062-5.
-
2004: Beauséjour Yannick; Tremblay Michel J
Interaction between the cytoplasmic domain of ICAM-1 and Pr55Gag leads to acquisition of host ICAM-1 by human immunodeficiency virus type 1.
Journal of virology 2004;78(21):11916-25.
-
2004: Vidricaire Gaël; Imbeault Michael; Tremblay Michel J
Endocytic host cell machinery plays a dominant role in intracellular trafficking of incoming human immunodeficiency virus type 1 in human placental trophoblasts.
Journal of virology 2004;78(21):11904-15.
-
2004: Zhao Chenqi; Papadopoulou Barbara; Tremblay Michel J
Leishmania infantum enhances human immunodeficiency virus type-1 replication in primary human macrophages through a complex cytokine network.
Clinical immunology (Orlando, Fla.) 2004;113(1):81-8.
-
2004: Beauséjour Yannick; Tremblay Michel J
Susceptibility of HIV type 1 to the fusion inhibitor T-20 is reduced on insertion of host intercellular adhesion molecule 1 in the virus membrane.
The Journal of infectious diseases 2004;190(5):894-902.
-
2004: Fortin Jean-François; Barat Corinne; Beauséjour Yannick; Barbeau Benoit; Tremblay Michel J
Hyper-responsiveness to stimulation of human immunodeficiency virus-infected CD4+ T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-kappaB, and AP-1 induction.
The Journal of biological chemistry 2004;279(38):39520-31.
-
2004: Vidricaire Gaël; Tremblay Michel J
[For a better understanding of the mechanisms involved in vertical transmission of HIV]
Médecine sciences : M/S 2004;20(8-9):784-7.
-
2004: Bounou Salim; Giguere Jean-François; Cantin Réjean; Gilbert Caroline; Imbeault Michael; Martin Geneviève; Tremblay Michel J
The importance of virus-associated host ICAM-1 in human immunodeficiency virus type 1 dissemination depends on the cellular context.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(11):1294-6.
-
2004: Martin Geneviève; Tremblay Michel J
HLA-DR, ICAM-1, CD40, CD40L, and CD86 are incorporated to a similar degree into clinical human immunodeficiency virus type 1 variants expanded in natural reservoirs such as peripheral blood mononuclear cells and human lymphoid tissue cultured ex vivo.
Clinical immunology (Orlando, Fla.) 2004;111(3):275-85.
-
2004: Beauséjour Yannick; Tremblay Michel J
Envelope glycoproteins are not required for insertion of host ICAM-1 into human immunodeficiency virus type 1 and ICAM-1-bearing viruses are still infectious despite a suboptimal level of trimeric envelope proteins.
Virology 2004;324(1):165-72.
-
2004: Barat Corinne; Gervais Philippe; Tremblay Michel J
Engagement of ICAM-3 provides a costimulatory signal for human immunodeficiency virus type 1 replication in both activated and quiescent CD4+ T lymphocytes: implications for virus pathogenesis.
Journal of virology 2004;78(12):6692-7.
-
2004: Giguère Jean-François; Bounou Salim; Paquette Jean-Sébastien; Madrenas Joaquín; Tremblay Michel J
Insertion of host-derived costimulatory molecules CD80 (B7.1) and CD86 (B7.2) into human immunodeficiency virus type 1 affects the virus life cycle.
Journal of virology 2004;78(12):6222-32.
-
2004: Zhao Chenqi; Papadopoulou Barbara; Tremblay Michel J
Leishmania infantum promotes replication of HIV type 1 in human lymphoid tissue cultured ex vivo by inducing secretion of the proinflammatory cytokines TNF-alpha and IL-1 alpha.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(5):3086-93.
-
2003: Tardif Mélanie R; Tremblay Michel J
Presence of host ICAM-1 in human immunodeficiency virus type 1 virions increases productive infection of CD4+ T lymphocytes by favoring cytosolic delivery of viral material.
Journal of virology 2003;77(22):12299-309.
-
2003: Dumais Nancy; Paré Marie-Eve; Mercier Simon; Bounou Salim; Marriot Susan J; Barbeau Benoit; Tremblay Michel J
T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1.
Journal of virology 2003;77(20):11170-9.
-
2003: Losier Martine; Fortin Jean François; Cantin Réjean; Bergeron Michel G; Tremblay Michel J
Virion-bound ICAM-1 and activated LFA-1: a combination of factors conferring resistance to neutralization by sera from human immunodeficiency virus type 1-infected individuals independently of the disease status and phase.
Clinical immunology (Orlando, Fla.) 2003;108(2):111-8.
-
2003: Ouellet Michel; Roy Jocelyn; Barbeau Benoit; Geleziunas Romas; Tremblay Michel J
NF-kappaB induction by bisperoxovanadium compounds requires CD45, p36(LAT), PKC, and IKK activity and exhibits kinetics of activation comparable to those of TCR/CD28 coengagement.
Biochemistry 2003;42(27):8260-71.
-
2003: Vidricaire Gaël; Tardif Mélanie R; Tremblay Michel J
The low viral production in trophoblastic cells is due to a high endocytic internalization of the human immunodeficiency virus type 1 and can be overcome by the pro-inflammatory cytokines tumor necrosis factor-alpha and interleukin-1.
The Journal of biological chemistry 2003;278(18):15832-41.
-
2003: Barat Corinne; Tremblay Michel J
Treatment of human T cells with bisperoxovanadium phosphotyrosyl phosphatase inhibitors leads to activation of cyclooxygenase-2 gene.
The Journal of biological chemistry 2003;278(9):6992-7000.
-
2003: Ouellet Michel; Barbeau Benoit; Tremblay Michel J
Protein tyrosyl phosphatases in T cell activation: implication for human immunodeficiency virus transcriptional activity.
Progress in nucleic acid research and molecular biology 2003;73():69-105.
-
2002: Barat Corinne; Tremblay Michel J
Adhesion molecules as costimulators: ICAM-3 signaling potentiates CD3-mediated HIV-1 stimulation.
Annals of the New York Academy of Sciences 2002;973():590-3.
-
2002: Roy Jocelyn; Paquette Jean-Sébastien; Fortin Jean-François; Tremblay Michel J
The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication.
Antimicrobial agents and chemotherapy 2002;46(11):3447-55.
-
2002: Ryckman Carle; Robichaud Gilles A; Roy Jocelyn; Cantin Réjean; Tremblay Michel J; Tessier Philippe A
HIV-1 transcription and virus production are both accentuated by the proinflammatory myeloid-related proteins in human CD4+ T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(6):3307-13.
-
2002: Giguère Jean-François; Paquette Jean-Sébastien; Bounou Salim; Cantin Réjean; Tremblay Michel J
New insights into the functionality of a virion-anchored host cell membrane protein: CD28 versus HIV type 1.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(5):2762-71.
-
2002: Janelle Marie-Eve; Gravel Annie; Gosselin Jean; Tremblay Michel J; Flamand Louis
Activation of monocyte cyclooxygenase-2 gene expression by human herpesvirus 6. Role for cyclic AMP-responsive element-binding protein and activator protein-1.
The Journal of biological chemistry 2002;277(34):30665-74.
-
2002: Barat Corinne; Tremblay Michel J
Engagement of CD43 enhances human immunodeficiency virus type 1 transcriptional activity and virus production that is induced upon TCR/CD3 stimulation.
The Journal of biological chemistry 2002;277(32):28714-24.
-
2002: Robichaud Gilles A; Barbeau Benoit; Fortin Jean-Francois; Rothstein David M; Tremblay Michel J
Nuclear factor of activated T cells is a driving force for preferential productive HIV-1 infection of CD45RO-expressing CD4+ T cells.
The Journal of biological chemistry 2002;277(26):23733-41.
-
2002: Sun Jiangfeng; Barbeau Benoit; Sato Sachiko; Boivin Guy; Goyette Nathalie; Tremblay Michel J
Syncytium formation and HIV-1 replication are both accentuated by purified influenza and virus-associated neuraminidase.
The Journal of biological chemistry 2002;277(12):9825-33.
-
2002: Gagné Jean-François; Désormeaux André; Perron Sylvie; Tremblay Michel J; Bergeron Michel G
Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes.
Biochimica et biophysica acta 2002;1558(2):198-210.
-
2002: Bounou Salim; Leclerc Jacques E; Tremblay Michel J
Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo.
Journal of virology 2002;76(3):1004-14.
-
2002: Dumais Nancy; Bounou Salim; Olivier Martin; Tremblay Michel J
Prostaglandin E(2)-mediated activation of HIV-1 long terminal repeat transcription in human T cells necessitates CCAAT/enhancer binding protein (C/EBP) binding sites in addition to cooperative interactions between C/EBPbeta and cyclic adenosine 5'-monophosphate response element binding protein.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(1):274-82.
-
2001: Cantin R; Martin G; Tremblay M J
A novel virus capture assay reveals a differential acquisition of host HLA-DR by clinical isolates of human immunodeficiency virus type 1 expanded in primary human cells depending on the nature of producing cells and the donor source.
The Journal of general virology 2001;82(Pt 12):2979-87.
-
2001: Barbeau B; Robichaud G A; Fortin J F; Tremblay M J
Negative regulation of the NFAT1 factor by CD45: implication in HIV-1 long terminal repeat activation.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(5):2700-13.
-
2001: Piret J; Gagné N; Perron S; Désormeaux A; Tremblay M J; Gourde P; Omar R F; Bergeron A M
Thermoreversible gel as a candidate barrier to prevent the transmission of HIV-1 and herpes simplex virus type 2.
Sexually transmitted diseases 2001;28(8):484-91.
-
2001: Bestman-Smith J; Piret J; Désormeaux A; Tremblay M J; Omar R F; Bergeron M G
Sodium lauryl sulfate abrogates human immunodeficiency virus infectivity by affecting viral attachment.
Antimicrobial agents and chemotherapy 2001;45(8):2229-37.
-
2001: Sun J; Barbeau B; Sato S; Tremblay M J
Neuraminidase from a bacterial source enhances both HIV-1-mediated syncytium formation and the virus binding/entry process.
Virology 2001;284(1):26-36.
-
2001: Genois N; Barbeau B; Olivier M; Tremblay M J
Inhibition of HIV-1-mediated syncytium formation and virus replication by the lipophosphoglycan from Leishmania donovani is due to an effect on early events in the virus life cycle.
Clinical and experimental immunology 2001;124(1):32-42.
-
2001: Fortin J F; Barbeau B; Robichaud G A; Paré M E; Lemieux A M; Tremblay M J
Regulation of nuclear factor of activated T cells by phosphotyrosyl-specific phosphatase activity: a positive effect on HIV-1 long terminal repeat-driven transcription and a possible implication of SHP-1.
Blood 2001;97(8):2390-400.
-
2001: Bélanger C; Gravel A; Tomoiu A; Janelle M E; Gosselin J; Tremblay M J; Flamand L
Human herpesvirus 8 viral FLICE-inhibitory protein inhibits Fas-mediated apoptosis through binding and prevention of procaspase-8 maturation.
Journal of human virology 2001;4(2):62-73.
-
2001: Bounou S; Dumais N; Tremblay M J
Attachment of human immunodeficiency virus-1 (HIV-1) particles bearing host-encoded B7-2 proteins leads to nuclear factor-kappa B- and nuclear factor of activated T cells-dependent activation of HIV-1 long terminal repeat transcription.
The Journal of biological chemistry 2001;276(9):6359-69.
-
2000: Genois N; Robichaud G A; Tremblay M J
Mono Mac 1: a new in vitro model system to study HIV-1 infection in human cells of the mononuclear phagocyte series.
Journal of leukocyte biology 2000;68(6):854-64.
-
2000: Bestman-Smith J; Désormeaux A; Tremblay M J; Bergeron M G
Targeting cell-free HIV and virally-infected cells with anti-HLA-DR immunoliposomes containing amphotericin B.
AIDS (London, England) 2000;14(16):2457-65.
-
2000: Bestman-Smith J; Gourde P; Désormeaux A; Tremblay M J; Bergeron M G
Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1.
Biochimica et biophysica acta 2000;1468(1-2):161-74.
-
2000: Savard M; Bélanger C; Tremblay M J; Dumais N; Flamand L; Borgeat P; Gosselin J
EBV suppresses prostaglandin E2 biosynthesis in human monocytes.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(12):6467-73.
-
2000: Fortin J F; Cantin R; Bergeron M G; Tremblay M J
Interaction between virion-bound host intercellular adhesion molecule-1 and the high-affinity state of lymphocyte function-associated antigen-1 on target cells renders R5 and X4 isolates of human immunodeficiency virus type 1 more refractory to neutralization.
Virology 2000;268(2):493-503.
-
1999: Ouellet M; Barbeau B; Tremblay M J
p56(lck), ZAP-70, SLP-76, and calcium-regulated effectors are involved in NF-kappaB activation by bisperoxovanadium phosphotyrosyl phosphatase inhibitors in human T cells.
The Journal of biological chemistry 1999;274(49):35029-36.
-
1999: Morin N J; Delorme C; Gourde P; Omar R F; Désormeaux A; Tremblay M J; Beauchamp D; Rousseau A; Bergeron M G
Reducing chorioretinal viral counts with intravitreal foscarnet injections in a rabbit model of Herpes simplex virus type-1 retinitis.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 1999;15(5):465-77.
-
1999: Dufresne I; Désormeaux A; Bestman-Smith J; Gourde P; Tremblay M J; Bergeron M G
Targeting lymph nodes with liposomes bearing anti-HLA-DR Fab' fragments.
Biochimica et biophysica acta 1999;1421(2):284-94.
-
1999: Fortin J F; Barbeau B; Hedman H; Lundgren E; Tremblay M J
Role of the leukocyte function antigen-1 conformational state in the process of human immunodeficiency virus type 1-mediated syncytium formation and virus infection.
Virology 1999;257(1):228-38.
-
1999: Gagné N; Cormier H; Omar R F; Désormeaux A; Gourde P; Tremblay M J; Juhász J; Beauchamp D; Rioux J E; Bergeron M G
Protective effect of a thermoreversible gel against the toxicity of nonoxynol-9.
Sexually transmitted diseases 1999;26(3):177-83.
-
1998: Paquette J S; Fortin J F; Blanchard L; Tremblay M J
Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity.
Journal of virology 1998;72(11):9329-36.
-
1998: Dumais N; Barbeau B; Olivier M; Tremblay M J
Prostaglandin E2 Up-regulates HIV-1 long terminal repeat-driven gene activity in T cells via NF-kappaB-dependent and -independent signaling pathways.
The Journal of biological chemistry 1998;273(42):27306-14.
-
1998: Barbeau B; Fortin J F; Genois N; Tremblay M J
Modulation of human immunodeficiency virus type 1-induced syncytium formation by the conformational state of LFA-1 determined by a new luciferase-based syncytium quantitative assay.
Journal of virology 1998;72(9):7125-36.
-
1998: Tremblay M J; Fortin J F; Cantin R
The acquisition of host-encoded proteins by nascent HIV-1.
Immunology today 1998;19(8):346-51.
-
1998: Bernier R; Barbeau B; Olivier M; Tremblay M J
Mycobacterium tuberculosis mannose-capped lipoarabinomannan can induce NF-kappaB-dependent activation of human immunodeficiency virus type 1 long terminal repeat in T cells.
The Journal of general virology 1998;79 ( Pt 6)():1353-61.
-
1998: Bernier R; Barbeau B; Tremblay M J; Olivier M
The lipophosphoglycan of Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor-kappaB elements.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(6):2881-8.
-
1998: Fortin J F; Cantin R; Tremblay M J
T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1.
Journal of virology 1998;72(3):2105-12.
Sign-in to see more